A

Ampersand Capital Partners

44 employees

Ampersand is a middle market private equity firm that focuses on healthcare and industrial sectors.

Investor insights

Countries invested in

united states2

Sectors invested in

Biotechnology23
Health Care15
Medical12
Telecommunications10
Wireless9
Pharmaceutical9
Manufacturing9
Software8
Life Science7
Medical Device6
Electronics5
Digital Marketing5
Programmatic Media5
Ad Tech5
market intelligence4
Enterprise Software4
Health Diagnostics4
Knowledge Management4
Analytics4
knowledge management4

Funding rounds participated in

$13M sweet spot round size

Most of their 64 investments are in rounds between $8.3M and $18M

Investor type

Private Equity Firm

Basic info

Industry

venture capital and private equity principals

Sectors

Angel Investment
Healthcare Services
Lab Products
Health Care
Financial Services
Finance
Specialty Pharma
Contract Manufacturing
Pharma Services
Lab Services
Venture Capital

Date founded

1988

Investments made

V

Vernal Biosciences raised $20M on June 27, 2023

Investors: VCET and Ampersand Capital Partners

N

NanoImaging Services raised undisclosed on June 12, 2023

Investors: Ampersand Capital Partners

S

Sterling Medical Devices raised undisclosed on June 23, 2022

Investors: Ampersand Capital Partners

A

AnaBios Corporation raised $6.5M on June 7, 2022

Investors: Ampersand Capital Partners

A

AnaBios Corporation raised $6.5M on June 7, 2022

Investors: Ampersand Capital Partners

V

Vernal Biosciences raised $21M on June 2, 2022

Investors: ATUM, Alloy Therapeutics, Inc and Ampersand Capital Partners

S

Syft Technologies raised undisclosed on April 18, 2022

Investors: Ampersand Capital Partners

B

BioEcho Life Sciences GmbH raised undisclosed on March 1, 2022

Investors: Ampersand Capital Partners

U

Undisclosed raised undisclosed on March 18, 2021

Investors: Ampersand Capital Partners

B

Brammer Bio raised undisclosed on January 1, 2021

Investors: Ampersand Capital Partners

FAQ